Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Army
Novartis
Cipla
Daiichi Sankyo
Harvard Business School
Cantor Fitzgerald
Fish and Richardson
Teva
UBS

Generated: August 22, 2017

DrugPatentWatch Database Preview

ROBINUL FORTE Drug Profile

« Back to Dashboard

Which patents cover Robinul Forte, and what generic Robinul Forte alternatives are available?

Robinul Forte is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in ROBINUL FORTE is glycopyrrolate. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.

Summary for Tradename: ROBINUL FORTE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list50
Clinical Trials: see list52
Patent Applications: see list2,028
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ROBINUL FORTE at DailyMed

Pharmacology for Tradename: ROBINUL FORTE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc
ROBINUL FORTE
glycopyrrolate
TABLET;ORAL012827-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ROBINUL FORTE

Drugname Dosage Strength RLD Submissiondate
glycopyrrolateTablets2 mgRobinul Forte10/12/2010
glycopyrrolateTablets1.5 mgRobinul Forte5/6/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Medtronic
Queensland Health
Johnson and Johnson
Mallinckrodt
McKesson
Cantor Fitzgerald
Julphar
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot